Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of

Acknowledgements

Membership of Hypofractionated Radiotherapy Working Group

This guideline was developed by a multidisciplinary working group convened by NBOCC*.

A/Prof Boon Chua (Chair) Radiation oncologist
Dr Marie-Frances Burke Radiation oncologist
Prof Geoff Delaney Radiation oncologist
Dr Jane O’Brien Breast surgeon
Ms Jan Rice Breast care nurse
Ms Geraldine Robertson Consumer representative
Dr Kirsty Stuart Radiation oncologist

NBOCC acknowledges the Breast Cancer Steering Committee, chaired by Dr Catherine Shannon, for their input into the development of this guideline.

NBOCC Staff

Ms Katrina Anderson Project Officer – Research
Ms Phillipa Hastings Project Officer
Dr Anne Nelson Evidence Review & Research Leader
Ms Sue Sinclair General Manager
Ms Heidi Wilcoxon Program Manager

 

External Review

NBOCC acknowledges those who gave their time to provide comment on the draft guideline recommendations as part of the external review process.

 

Topic-specific guideline development process

Priority topic areas for guideline development are determined in consultation with key stakeholders including experts in relevant disciplines and consumer representatives. A specific multidisciplinary Working Group, including consumers, is established for each topic identified and is involved in all aspects of guideline development. A systematic evidence review is undertaken for each guideline. All members are asked to declare any conflicts of interest and these declarations are recorded.  The content of the guideline is not influenced by any external funding body. The guideline is reviewed externally by key stakeholders and the wider community and endorsement is sought from relevant professional colleges and groups in Australia.

Acknowledgement

The National Breast Cancer Foundation provided funding for the development and production of this guideline. 

* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Published using CeCC Docbook Manager